Skip Navigation

Human Molecular Genetics 2008 17(R1):R67-R75; doi:10.1093/hmg/ddn065
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yeo, G. W.
Right arrow Articles by Gage, F. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yeo, G. W.
Right arrow Articles by Gage, F. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

This article appears in the following Human Molecular Genetics issue: Stem Cells and Regeneration [View the issue table of contents]

Multiple layers of molecular controls modulate self-renewal and neuronal lineage specification of embryonic stem cells

Gene W. Yeo1,2,{dagger}, Nicole Coufal1,{dagger}, Stefan Aigner1, Beate Winner1, Jonathan A. Scolnick1, Maria C.N. Marchetto1, Alysson R. Muotri1, Christian Carson3 and Fred H. Gage1,*

1 Laboratory of Genetics 2 Crick-Jacobs Center for Computational and Theoretical Biology, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA 3 BD Biosciences, 11077 North Torrey Pines Road, La Jolla, CA 92037, USA

* To whom correspondence should be addressed. Email: gage{at}salk.edu

Received February 13, 2008; Revised February 13, 2008; Accepted February 28, 2008

Elucidating the molecular changes that arise during neural differentiation and fate specification is crucial for building accurate in vitro models of neurodegenerative diseases using human embryonic stem cells (hESCs). Here we review the importance of hESCs and derived progenitors in treating and modeling neurological diseases, and summarize the current efforts for the differentiation of hESCs into neural progenitors and defined neurons. We recapitulate the recent findings and discuss open questions on aspects of molecular control of gene expression by chromatin modification and methylation, posttranscriptional regulation by alternative splicing and the action of microRNAs, and protein modification. An integrative view of the different levels will hopefully provide much needed insight into understanding stem cell biology.


{dagger} These authors contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.